CRMD
CorMedix Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -11.1% ·
aliran saham +6.0% ·
posisi baru bersih -12.5%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 33.01K | $241,641 | n/a | n/a |
| Q2 2026 | 82 | +2 | 27.12M | $212.84M | +4 | −4 |
| Q1 2026 | 85 | -1 | 25.38M | $172.62M | +10 | −11 |
| Q4 2025 | 85 | +1 | 28.40M | $330.32M | +1 | n/a |
| Q3 2025 | 16 | -2 | 20.70M | $240.74M | +1 | −3 |
| Q2 2025 | 15 | +1 | 18.26M | $224.97M | +2 | −1 |
| Q1 2025 | 11 | 0 | 6.59M | $40.58M | +1 | −1 |
| Q4 2024 | 11 | +1 | 7.02M | $56.86M | +2 | −1 |
| Q3 2024 | 9 | -2 | 3.76M | $30.38M | n/a | −2 |
| Q2 2024 | 11 | n/a | 4.01M | $17.37M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 5.69M | +6.1% | $66.15M | 0.0% | ▲ Add | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (pasif) | 3.98M | -8.0% | $46.26M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Marshall Wace ✦ | 3.47M | +34.6% | $40.40M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (pasif) | 1.84M | +14.6% | $21.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.81M | +13.4% | $21.05M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.72M | +0.2% | $19.97M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 843.57K | n/a | $9.81M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | Millennium Management ✦ | 395.45K | +602.6% | $4.60M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 250.37K | +46.3% | $2.91M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 10 | Goldman Sachs Group ✦ | 230.81K | n/a | $2.68M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 194.46K | n/a | $2.26M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Two Sigma Investments ✦ | 128.56K | -59.4% | $1.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 75.69K | -23.3% | $880,298 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 39.27K | +22.3% | $457,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 31.36K | Baru | $364,775 | 0.0% | New | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 8.38K | +7.8% | $97,503 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Gotham Asset Management | $364,775 | 0.0% |
Telah keluar
| D. E. Shaw & Co. | $2.71M | adalah 0.0% |
| Renaissance Technologies | $1.88M | adalah 0.0% |
| Point72 Asset Management | $345,443 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 184 pemegang, 40.43M saham, $271.85M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.